Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Morel

Showing results (291-300 of 444) with videos related to

Pageof 45
Sort By:
European Journal of Endocrinology|December 10, 2009
45,X/46,XX mosaicism below 30% of aneuploidy: clinical implications in adult women from a reproductive medicine unitL Homer, M-T Le Martelot, F Morel, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|July 1, 1979
[Assisted ventilation of newborn infants during sleep. Study of factors modifying adaptation to ventilation]M F Radvanyi, L Curzi-Dascalova, G Korn, et al.
American Journal of Medical Genetics. Part A|June 24, 2004
Molecular cytogenetic characterization of two small chromosome 8 derived supernumerary mosaic markersA Herry, F Morel, M-J Le Bris, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2012
Does 45,X/46,XX mosaicism with 6-28% of aneuploidy affect the outcomes of IVF or ICSI?L Homer, F Morel, F Gallon, et al.
Cellular Immunology|May 25, 1997
Modeling the proliferative response of T cells to IL-2 and IL-4M A Burke, B F Morel, T B Oriss, et al.
Cancer Research|December 1, 1995
Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary cultureS Langouët, B Coles, F Morel, et al.
Leukemia|June 2, 2007
A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemiaE De Braekeleer, N Douet-Guilbert, M-J Le Bris, et al.
Bulletin of Mathematical Biology|May 1, 1996
Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical modelB F Morel, M A Burke, J Kalagnanam, et al.
Leukemia|November 28, 2002
Isolated granulocytic sarcoma followed by acute myelogenous leukemia type FAB-M2 associated with inversion 16 and trisomies 9 and 22F Morel, A Herry, M-J Le Bris, et al.
Pageof 45

Showing results (291-300 of 444) with videos related to

Sort By:
Pageof 45
European Journal of Endocrinology|December 10, 2009
45,X/46,XX mosaicism below 30% of aneuploidy: clinical implications in adult women from a reproductive medicine unitL Homer, M-T Le Martelot, F Morel, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|July 1, 1979
[Assisted ventilation of newborn infants during sleep. Study of factors modifying adaptation to ventilation]M F Radvanyi, L Curzi-Dascalova, G Korn, et al.
American Journal of Medical Genetics. Part A|June 24, 2004
Molecular cytogenetic characterization of two small chromosome 8 derived supernumerary mosaic markersA Herry, F Morel, M-J Le Bris, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2012
Does 45,X/46,XX mosaicism with 6-28% of aneuploidy affect the outcomes of IVF or ICSI?L Homer, F Morel, F Gallon, et al.
Cellular Immunology|May 25, 1997
Modeling the proliferative response of T cells to IL-2 and IL-4M A Burke, B F Morel, T B Oriss, et al.
Cancer Research|December 1, 1995
Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary cultureS Langouët, B Coles, F Morel, et al.
Leukemia|June 2, 2007
A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemiaE De Braekeleer, N Douet-Guilbert, M-J Le Bris, et al.
Bulletin of Mathematical Biology|May 1, 1996
Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical modelB F Morel, M A Burke, J Kalagnanam, et al.
Leukemia|November 28, 2002
Isolated granulocytic sarcoma followed by acute myelogenous leukemia type FAB-M2 associated with inversion 16 and trisomies 9 and 22F Morel, A Herry, M-J Le Bris, et al.
Pageof 45